Your browser doesn't support javascript.
loading
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance.
Santilli, Francesca; Zaccardi, Francesco; Liani, Rossella; Petrucci, Giovanna; Simeone, Paola; Pitocco, Dario; Tripaldi, Romina; Rizzi, Alessandro; Formoso, Gloria; Pontecorvi, Alfredo; Angelucci, Ermanno; Pagliaccia, Francesca; Golato, Maria; De Leva, Francesca; Vitacolonna, Ester; Rocca, Bianca; Consoli, Agostino; Patrono, Carlo.
Afiliação
  • Santilli F; Department of Medicine and Aging and Center of Aging Science and Translational Medicine (CESI-Met), University of Chieti "G. D'Annunzio" School of Medicine, Chieti, Italy.
  • Zaccardi F; Diabetes Care Unit, Catholic University School of Medicine and Fondazione Policlinico Universitario "A. Gemelli" Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Liani R; Leicester Diabetes Centre, Leicester General Hospital, Leicester, United Kingdom.
  • Petrucci G; Department of Medicine and Aging and Center of Aging Science and Translational Medicine (CESI-Met), University of Chieti "G. D'Annunzio" School of Medicine, Chieti, Italy.
  • Simeone P; Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy.
  • Pitocco D; Department of Medicine and Aging and Center of Aging Science and Translational Medicine (CESI-Met), University of Chieti "G. D'Annunzio" School of Medicine, Chieti, Italy.
  • Tripaldi R; Diabetes Care Unit, Catholic University School of Medicine and Fondazione Policlinico Universitario "A. Gemelli" Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Rizzi A; Department of Medicine and Aging and Center of Aging Science and Translational Medicine (CESI-Met), University of Chieti "G. D'Annunzio" School of Medicine, Chieti, Italy.
  • Formoso G; Diabetes Care Unit, Catholic University School of Medicine and Fondazione Policlinico Universitario "A. Gemelli" Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Pontecorvi A; Department of Medicine and Aging and Center of Aging Science and Translational Medicine (CESI-Met), University of Chieti "G. D'Annunzio" School of Medicine, Chieti, Italy.
  • Angelucci E; Institute of Endocrinology, Catholic University School of Medicine and Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.
  • Pagliaccia F; Department of Clinical Medicine, Chieti University Hospital, Chieti, Italy.
  • Golato M; Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy.
  • De Leva F; Department of Clinical Pathology, Chieti University Hospital, Chieti, Italy.
  • Vitacolonna E; Diabetes Care Unit, Catholic University School of Medicine and Fondazione Policlinico Universitario "A. Gemelli" Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Rocca B; Department of Medicine and Aging and Center of Aging Science and Translational Medicine (CESI-Met), University of Chieti "G. D'Annunzio" School of Medicine, Chieti, Italy.
  • Consoli A; Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy.
  • Patrono C; Department of Medicine and Aging and Center of Aging Science and Translational Medicine (CESI-Met), University of Chieti "G. D'Annunzio" School of Medicine, Chieti, Italy.
Diabetes Metab Res Rev ; 36(2): e3232, 2020 02.
Article em En | MEDLINE | ID: mdl-31671234
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ativação Plaquetária / Tromboxanos / Intolerância à Glucose / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ativação Plaquetária / Tromboxanos / Intolerância à Glucose / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2020 Tipo de documento: Article